JP2019147836A5 - - Google Patents

Download PDF

Info

Publication number
JP2019147836A5
JP2019147836A5 JP2019097670A JP2019097670A JP2019147836A5 JP 2019147836 A5 JP2019147836 A5 JP 2019147836A5 JP 2019097670 A JP2019097670 A JP 2019097670A JP 2019097670 A JP2019097670 A JP 2019097670A JP 2019147836 A5 JP2019147836 A5 JP 2019147836A5
Authority
JP
Japan
Prior art keywords
cells
nutritional supplement
composition
fatty acids
lysolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019097670A
Other languages
English (en)
Japanese (ja)
Other versions
JP6970709B2 (ja
JP2019147836A (ja
Filing date
Publication date
Priority claimed from JP2016513125A external-priority patent/JP6533519B2/ja
Application filed filed Critical
Publication of JP2019147836A publication Critical patent/JP2019147836A/ja
Publication of JP2019147836A5 publication Critical patent/JP2019147836A5/ja
Application granted granted Critical
Publication of JP6970709B2 publication Critical patent/JP6970709B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019097670A 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉 Expired - Fee Related JP6970709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822095P 2013-05-10 2013-05-10
US61/822,095 2013-05-10
JP2016513125A JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016513125A Division JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉

Publications (3)

Publication Number Publication Date
JP2019147836A JP2019147836A (ja) 2019-09-05
JP2019147836A5 true JP2019147836A5 (cg-RX-API-DMAC7.html) 2020-01-16
JP6970709B2 JP6970709B2 (ja) 2021-11-24

Family

ID=51867773

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513125A Active JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉
JP2019097670A Expired - Fee Related JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016513125A Active JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉

Country Status (7)

Country Link
US (2) US10130600B2 (cg-RX-API-DMAC7.html)
EP (1) EP2993980B1 (cg-RX-API-DMAC7.html)
JP (2) JP6533519B2 (cg-RX-API-DMAC7.html)
AU (3) AU2014262450A1 (cg-RX-API-DMAC7.html)
CA (2) CA3136947C (cg-RX-API-DMAC7.html)
IL (2) IL242492B (cg-RX-API-DMAC7.html)
WO (1) WO2014183047A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
EP2968988A4 (en) 2013-03-14 2016-11-16 Allegro Diagnostics Corp METHOD FOR EVALUATING A COPD STATUS
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
US11369588B2 (en) 2014-03-20 2022-06-28 The Trustees Of Princeton University NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
AU2018230784A1 (en) 2017-03-09 2019-10-10 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
US12653836B2 (en) 2020-07-15 2026-06-16 The Trustees Of Princeton University Ketogenic diet and ketone supplementation for cancer therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183815T3 (es) 1992-07-24 2003-04-01 Univ Johns Hopkins Quimioterapia para el cancer.
EP0929694A4 (en) * 1996-03-15 2002-05-02 Penn State Res Found DETECTION OF TUMOR-RELATED EXTRACELLULAR NUCLEIC ACID USING PLASMA OR BLOOD SERUM USING NUCLEIC ACID AMPLIFICATION TESTS
US6214875B1 (en) 1998-04-14 2001-04-10 Zhenhua Yang Anticancer effects of specific branched-chain fatty acids and related production process
JP5511126B2 (ja) 2003-03-27 2014-06-04 サントリーホールディングス株式会社 脂質改善剤及び脂質改善剤を含んでなる組成物
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
WO2008147562A2 (en) * 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
WO2012165345A1 (ja) * 2011-05-27 2012-12-06 株式会社明治 がんに伴う不可逆性の代謝障害の予防及び/又は改善のための組成物
CN103608023A (zh) 2011-06-15 2014-02-26 稳定解决方案有限责任公司 磷虾油的胃肠外治疗应用
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers

Similar Documents

Publication Publication Date Title
US11400105B2 (en) Anti-inflammatory properties of marine lipid compositions
JP2011137015A5 (cg-RX-API-DMAC7.html)
Jump et al. Omega-3 fatty acid supplementation and cardiovascular disease: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases
Betancor et al. Influence of dietary docosahexaenoic acid in combination with other long-chain polyunsaturated fatty acids on expression of biosynthesis genes and phospholipid fatty acid compositions in tissues of post-smolt Atlantic salmon (Salmo salar)
Kaur et al. Short-term docosapentaenoic acid (22: 5n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats
JP2008542280A5 (cg-RX-API-DMAC7.html)
JP2010162032A5 (cg-RX-API-DMAC7.html)
PH12016501194A1 (en) Lipid comprising long chain polyunsaturated fatty acids
CN103609933A (zh) 一种用于肿瘤患者的肠内营养乳剂
JP2016521286A5 (cg-RX-API-DMAC7.html)
WO2013153071A3 (en) A nutritional composition
WO2008147562A3 (en) Dietary formulations and methods for treatment of inflammation and other disorders
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
Chapkin et al. Dietary manipulation of macrophage phospholipid classes: selective increase of dihomogammalinolenic acid
WO2014089511A3 (en) Administering compositions comprising docosapentaenoic acid
PH12019501255A1 (en) Nutritional composition for improving cell membranes
JP2016501248A5 (cg-RX-API-DMAC7.html)
WO2011137160A3 (en) Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
Zuo et al. Effects of short‐term supplementation with DHA‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA‐deficient mice in early life after weaning
Saito et al. Characteristics of lipid composition differences between cultured and wild ayu (Plecoglossus altivelis)
Schnebelen et al. Dietary n-3 and n-6 PUFA enhance DHA incorporation in retinal phospholipids without affecting PGE1 and PGE2 levels
HK1201744A1 (en) Composition for improving neuropsychological test battery score
Wang et al. The rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice
JP2016086757A5 (cg-RX-API-DMAC7.html)